What this page helps you do
Use this guide to prepare a Bosnia and Herzegovina adult hematology file, identify the responsible local referral or insurance route and keep clinical review separate from administrative authorization.
- Before hospital review
- Confirm which local institution and insurer are responsible for the patient. A Turkish specialist opinion and a domestic funding or referral decision are separate processes.
- Documents
- Request a dated hematology summary plus the original pathology, marrow and molecular reports, prior-treatment chronology, response and current organ-function results.
- Travel
- Published rules exempt Bosnia and Herzegovina passport holders for short stays, but general entry permission does not itself authorize travel for treatment. Confirm the medical purpose, documents and expected stay before booking.
- Continuity of care
- Agree which local hematology service will receive the specialist response and manage medicines, blood counts, infection risks and urgent complications after return.
- The cited Federation pathway is jurisdiction- and insurance-specific; it must not be presented as automatically available to every resident of Bosnia and Herzegovina.
- A domestic referral or funding decision does not guarantee acceptance by a hospital in Turkey, and hospital review does not guarantee public funding.
- General entry or short-stay visa-exemption rules do not themselves authorize travel for treatment. Medical-purpose requirements must be reconfirmed for the individual case.
Travel information checked 11 October 2026. Reconfirm requirements before booking.
Adult BMT Evaluation in Turkey from Bosnia and Herzegovina
Adults in Bosnia and Herzegovina may request a remote review when a treating hematologist is considering bone marrow or hematopoietic stem-cell transplantation. Review before travel helps identify missing records but does not confirm eligibility or admission.
Care in Bosnia and Herzegovina and an International Review Are Separate
Bosnia and Herzegovina has multiple responsible health institutions. The Federation’s health insurance and reinsurance institute lists bone-marrow transplantation among treatments that may be referred abroad under its rules, after domestic diagnostic and treatment options are assessed. This does not apply automatically to every resident or guarantee authorization, destination or hospital acceptance.
This page does not claim that appropriate hematology care is unavailable in Bosnia and Herzegovina. A Turkish hospital review is an additional, case-specific option rather than a conclusion about the national health system.
Anadolu Adult Bone Marrow Transplant Program
Anadolu’s official sources describe a dedicated adult center with inpatient, outpatient, HLA-typing, hemapheresis and stem-cell processing services. Anadolu is the published partner for this campaign, not the only program a patient may consider.
Autologous or Allogeneic Is a Clinical Decision
Autologous or allogeneic transplantation, conditioning intensity, stem-cell source and timing can only be selected after the adult transplant team reviews the diagnosis, disease status, prior treatment, organ function and alternatives.
A preliminary referral must not be interpreted as a recommendation for either type.
Potential Donor Information and HLA Review
A relative or other possible donor is not automatically suitable. Allogeneic transplantation requires hospital-led HLA testing, medical assessment, informed consent and any applicable legal or registry checks.
MedTransplant does not source donors and cannot confirm whether a family member or registry route is available for a particular case.
Preparing Records in Bosnia and Herzegovina
Organize the latest information without delaying urgent local care.
- Treating hematologist’s diagnosis, disease status and precise referral question
- Pathology, marrow, flow-cytometry, cytogenetic and molecular reports
- Treatment cycles, response, complications and transfusion history
- Recent blood counts, infection screening and organ-function assessment
- Available HLA or possible-donor information only when requested
- Any insurer or competent-authority referral decision kept separate from the clinical file
From Case Review to Specialist Response
MedTransplant checks the file structure, coordinates submission to the appropriate program and communicates requests or a preliminary response. The hospital may request new pathology review, testing or consultation.
Request a Hospital-Program Comparison
Patients may also explore other verified hospital programs or request comparison through MedTransplant. The useful comparison is based on review scope, clinical fit and logistics—not unsupported claims of superiority.
Planning Travel from Bosnia and Herzegovina
Travel should normally follow a meaningful hospital response. Clarify who must travel, which tests are required, expected assessment stages and how long the patient may need to remain near the center.
Case-Specific Financial Planning
No unverified price is stated. If the center can progress the case, any quotation may depend on diagnostics, donor evaluation, cell collection, conditioning, admission and the proposed care plan.
Follow-up After Returning to Bosnia and Herzegovina
Coordinate with a local hematology team before treatment. Monitoring medicines, infections, blood counts, immune recovery and urgent complications must remain continuous after return.
Continue with the Anadolu Adult BMT Guide
Review the partner-program evaluation pathway, clinical boundaries and records required for a preliminary assessment.
Explore adult BMT evaluation at AnadoluFrequently Asked Questions
Can a case from Bosnia and Herzegovina be reviewed before travel?
Available records can be prepared for preliminary specialist review. This does not guarantee acceptance or an in-person appointment.
Is bone marrow transplant the same as stem-cell transplant?
Bone marrow is one possible source of blood-forming stem cells. The appropriate terminology and source depend on the proposed clinical pathway.
Who decides between autologous and allogeneic transplant?
The responsible transplant team decides after reviewing the diagnosis, disease status, prior treatment, health and possible cell sources.
Does a willing relative qualify as a donor?
Not automatically. HLA matching, donor health, consent and applicable legal or registry requirements require separate assessment.
Can MedTransplant find a donor?
No. MedTransplant does not find, recruit, sell, broker or guarantee stem-cell donors.
Does submission guarantee acceptance?
No. Submission guarantees neither hospital acceptance, donor suitability, transplantation, timing nor outcome.
Can I compare Anadolu with another hospital?
Yes. Anadolu is the published partner for this campaign, while patients may explore other verified programs or request a comparison through MedTransplant.
When should travel be booked?
Generally after the hospital has reviewed the available file and described the next possible assessment steps.
Sources and verification
- Anadolu Medical Center: Bone Marrow Transplant Center
- Anadolu Medical Center: Gebze hospital
- Anadolu Medical Center: Hematologic Oncology
- National Cancer Institute: Stem cell transplants in cancer treatment
- National Cancer Institute: Blood stem cell donation
- ZZOR FBiH: Notice on treatment in health institutions abroad
- ZZOR FBiH: Rules for referring insured persons for treatment abroad
- Federation Ministry of Health: Centre for Transplantation Medicine
- Türkiye Ministry of Foreign Affairs: Visa information for foreigners
- Türkiye Ministry of Foreign Affairs: General information about Turkish visas
Medical responsibility
MedTransplant coordinates case preparation and referral. It does not provide medical advice, determine eligibility, select a cell source, arrange donors or guarantee acceptance, timing or outcomes.
